Doc. #757631v.1

                                                                                                                        Doc. #757631v.1



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934

                               (Amendment No. 8)*

                        Blonder Tongue Laboratories, Inc.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                   093698 10 8
                                 (CUSIP Number)


                                 January 2, 2004
             (Date of Event Which Required Filing of this Statement)


Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

     [ ] Rule 13d-1(b)

     [ ] Rule 13d-1(c)

     [X ] Rule 13d-1(d)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).





CUSIP No. - 093698 10 8

     1    NAME OF REPORTING  PERSON S.S. or I.R.S.  IDENTIFICATION  NO. OF ABOVE
          PERSON

          James A. Luksch


     2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

          (a)      /_/
          (b)      /_/
          N/A


     3    SEC USE ONLY


     4    CITIZENSHIP OR PLACE OF ORGANIZATION 

          United States of America


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH


     5    SOLE VOTING POWER

          1,321,192  shares of Common Stock  (includes  64,286  shares of Common
          Stock owned by the spouse of James A.  Luksch,  5,464 shares of Common
          Stock owned by the 1988 Irrevocable Trust A of Herbert M. Luksch,  the
          trustee  of which is James A.  Luksch,  5,464  shares of Common  Stock
          owned  by the 1988  Irrevocable  Trust B of  Herbert  M.  Luksch,  the
          trustee  of which is James A.  Luksch,  and 9 Shares of  Common  Stock
          owned by the Estate of Herbert M.  Luksch,  the  executor  of which is
          James A. Luksch)


     6    SHARED VOTING POWER

          N/A


     7    SOLE DISPOSITIVE POWER

          1,321,192  shares of Common Stock  (includes  64,286  shares of Common
          Stock owned by the spouse of James A.  Luksch,  5,464 shares of Common
          Stock owned by the 1988 Irrevocable Trust A of Herbert M. Luksch,  the
          trustee  of which is James A.  Luksch,  5,464  shares of Common  Stock
          owned  by the 1988  Irrevocable  Trust B of  Herbert  M.  Luksch,  the
          trustee  of which is James A.  Luksch,  and 9 Shares of  Common  Stock
          owned by the Estate of Herbert M.  Luksch,  the  executor  of which is
          James A. Luksch)


     8    SHARED DISPOSITIVE POWER

          N/A


     9    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          1,321,192  shares of Common Stock  (includes  64,286  shares of Common
          Stock owned by the spouse of James A.  Luksch,  5,464 shares of Common
          Stock owned by the 1988 Irrevocable Trust A of Herbert M. Luksch,  the
          trustee  of which is James A.  Luksch,  5,464  shares of Common  Stock
          owned  by the 1988  Irrevocable  Trust B of  Herbert  M.  Luksch,  the
          trustee  of which is James A.  Luksch,  and 9 Shares of  Common  Stock
          owned by the Estate of Herbert M.  Luksch,  the  executor  of which is
          James A. Luksch)


     10   CHECK BOX IF THE AGGREGATE  AMOUNT IN ROW (9) EXCLUDES  CERTAIN SHARES
          /_/

          N/A


                                       2



     11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

          16.5%


     12   TYPE OF REPORTING PERSON

          IN


                                       3


Item 1.

     (a) Name of Issuer: Blonder Tongue Laboratories, Inc.

     (b) Address of Issuer's  Principal  Executive Office:  One Jake Brown Road,
Old Bridge, New Jersey 08857.


Item 2.

     (a)  Name of Person Filing: James A. Luksch

     (b)  Address  of  Principal  Business  Office or, if none,  Residence:  c/o
Blonder Tongue  Laboratories,  Inc., One Jake Brown Road, Old Bridge, New Jersey
08857.

     (c) Citizenship: United States of America

     (d) Title of the Class of Securities: Common Stock

     (e) CUSIP number: 093698 10 8


Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c),
     check whether the person filing is a:

     (a) [ ] Broker or dealer  registered under section 15 of the Act (15 U.S.C.
78o).

     (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     (c) [ ]  Insurance  company as defined in section  3(a)(19)  of the Act (15
U.S.C. 78c).

     (d) [ ] Investment  company  registered  under section 8 of the  Investment
Company Act of 1940 (15 U.S.C. 80a-8).

     (e) [ ] An investment adviser in accordance withss.240.13d- 1(b)(1)(ii)(E);

     (f)  [  ]  An  employee  benefit  plan  or  endowment  fund  in  accordance
withss.240.13d-1(b)(1)(ii)(F);

     (g)  [  ]  A  parent  holding  company  or  control  person  in  accordance
withss.240.13d-1(b)(1)(ii)(G);

     (h) [ ] A savings  association  as defined in Section  3(b) of the  Federal
Deposit Insurance Act (12 U.S.C. 1813);

     (i) [ ] A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment  Company Act of 1940 (15 U.S.C.
80a-3);

     (j) [ ] Group, in accordance withss.240.13d-1(b)(1)(ii)(J);


Item 4. Ownership

     See item nos. 5 through 11 of the second part of the cover sheet.


Item 5. Ownership of Five Percent or Less of a Class

     N/A


                                       4


Item 6. Ownership of More than Five Percent on Behalf of Another Person

     James A. Luksch is the indirect beneficial owner of 64,286 shares of Common
     Stock  that are owned by his  spouse,  who has the right to  receive or the
     power to direct the receipt of dividends  from,  or the  proceeds  from the
     sale of, such shares.


Item 7.  Identification  and Classification of the Subsidiary Which Acquired the
     Security Being Reported on By the Parent Holding Company

                  N/A


Item 8.  Identification and Classification of Members of the Group

                  N/A


Item 9.  Notice of Dissolution of Group

                  N/A


Item 10. Certification

     N/A


                                       5



                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

                                                    February 14, 2005        
                                                        Date


                                                     /s/ James A. Lutsch     
                                                        Signature


                                                        James A. Luksch
                                                     Chief Executive Officer 
                                                        Name/Title